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After more than 150 years of research on the subject, it is now well
established that mental disorders are associated with excess
mortality.1–3 The association between depression and excess
mortality has been shown in several hundreds of studies in many
different populations, including community samples, heart disease
patients, cancer patients, stroke patients and patients with
diabetes.4–15 It is not yet clear, however, whether the increased
mortality rates only exist in major depressive disorder, or also
extend to subthreshold depression. Many studies examining excess
mortality in depression have used a cut-off score on self-report
instruments to indicate the presence of depressive symptoms. It
is possible that the increased mortality rate in these samples can
be fully attributed to the people with major depression. However,
it is also possible that the increased mortality rate exists not only
in major depression but also in subthreshold depression. Many
studies have shown that subthreshold depression in itself is a clini-
cally relevant condition, with decreased levels of health-related
quality of life, increased use of health services and increased
economic costs when compared with healthy controls.16–19 When
people with subthreshold depression are compared with those
who have a major depressive disorder, however, it is typically
found that on an individual level health-related quality of life,
health service use and economic costs are more affected in major
depression than in subthreshold depression. From this perspective
it would be expected that if there is an association between excess
mortality and subthreshold depression it would be less strong than
in major depression. Because the prevalence of subthreshold
depression is higher than that of major depression, earlier research
has found that the impact of subthreshold depression on (for
example) economic costs is comparable with the costs of major
depression.20 The same may be true for the impact of subthreshold
and major depression on mortality. In order to examine these
questions, a meta-analysis of studies in which participants with
major depression as well as those with subthreshold depression
were included would be most informative. These studies allow
comparison of major and subthreshold depression directly with
each other and establish whether excess mortality is higher in
major depression than in subthreshold depression. We decided
to conduct such a meta-analysis.
Method
Studies were traced by several methods. First, we conducted
comprehensive literature searches (up to November 2011) in three
bibliographic databases (PubMed, PsycINFO and EMBASE). In
these searches we combined words indicating depression (such
as major depression, mood disorder, depression, depressive),
mortality (such as death, survival), and prospective design (such
as incidence, follow-up studies, longitudinal studies, prospective
studies). Both text and keywords were used. We also checked
the references of included studies, as well as the references of
earlier meta-analyses examining the association between
depression and mortality.5–13,21–27 We retrieved the full text of
papers reporting studies that possibly met inclusion criteria.
Full-text papers were examined by two independent raters for
possible inclusion. Disagreements were solved by discussion and
if necessary a third rater was involved.
Studies were included if they examined two groups: participants
with a major depressive disorder (established with a diagnostic
interview; either major depression alone or combined with
dysthymia); and participants with subthreshold depression
(established through a self-report depression measure or a
diagnostic interview) but no major depressive disorder. Studies
also had to have a prospective design and report all-cause
mortality at follow-up, for both groups. We included studies in
any target group (community samples and specific patient
groups), as well as case–control studies. Studies were excluded
when insufficient data were presented to calculate the relative risk
of dying in the group with major depression compared with
subthreshold depression (main analysis). We also excluded studies
based on trials examining the effects of an intervention, studies in
children and adolescents, and studies in languages other than
English, German and Dutch.
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Background
Although the association between depression and excess
mortality has been well established, it is not clear whether
this is greater in major depression than in subthreshold
depression.
Aims
To compare excess mortality in major depression with that in
subthreshold depression.
Method
We searched bibliographic databases and included
prospective studies in which both major and subthreshold
depression were examined at baseline and mortality was
measured at follow-up.
Results
A total of 22 studies were included. People with major
depression had a somewhat increased chance of dying
earlier than people with subthreshold depression but this
difference was not significant, although there was a trend
(relative risk 1.13, 95% CI 0.98–1.30, P= 0.1). The population
attributable fraction was 7% for major depression and an
additional 7% for subthreshold depression.
Conclusions
Although excess mortality may be somewhat higher in major
than in subthreshold depression, the difference is small and
the overall impact on excess mortality is comparable.
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Data extraction and quality assessment
We rated the number of deaths in the group with major
depression, the group with subthreshold depression and the
non-depressed control group. When these data were not reported
in the papers, we contacted the first authors of the studies. If no
answer was received within 2 weeks, a reminder was sent.
Additional data on six studies were received from the researchers
(see Acknowledgements). For the subgroup (moderator) analyses
we rated several characteristics of the included studies: target
population (community sample, heart disease patients, other
patient group); percentage of women in the target population
(540%, 40–60%, 460%); definition of subthreshold depression
(scoring above a cut-off on self-report measure v. fulfilling
diagnostic DSM–IV criteria for minor depression); follow-up
period (52 years, 2–5 years, 45 years); and country where the
study was conducted (USA, Europe, other).
In order to assess the validity of the studies we used a quality
rating scale that was based on the instrument developed by
Hayden et al.28 We adapted the specific items for use with the
studies in this field, but retained five of the six basic areas of
potential bias that are assessed with this instrument: study
participation (the study sample represents the population of
interest on key characteristics), study attrition, adequate outcome
measurement, adequate measurement of confounding variables
and adequate statistical analysis. The sixth area of potential bias
(the prognostic factor of interest is adequately measured) was
not used because an adequate measure of depression (major and
subthreshold) was an inclusion criterion for this study. The rating
instrument is presented online in Appendix DS1, and the ratings
for the included studies are presented in online Table DS1.
Meta-analyses
For each study we calculated the relative risk of dying during the
study in the group with major depression compared with the
group with subthreshold depression. This was the main comparison
for each study. However, all studies also included a non-depressed
control group. We also calculated the relative risks of dying for the
groups with major depression and subthreshold depression
compared with the non-depressed group. Because we did not
collect all studies that compared major depression or subthreshold
depression with non-depressed controls, these comparisons
should be considered with caution; we conducted these analyses
only to confirm that earlier associations between depression and
excess mortality were also found in our sample of studies.
Because all studies reported the exact number of deaths in the
depressed and non-depressed groups, unadjusted relative risks
(RRs) were calculated for all studies. None of the studies reported
RRs (comparing major depression with subthreshold depression)
that were adjusted for demographics or other variables. Therefore,
all analyses were conducted with unadjusted RRs. To calculate
pooled RRs we used the computer program Comprehensive
Meta-analysis for Windows version 2.2.021. As we expected
considerable heterogeneity among the studies, we decided to
calculate the pooled RR using a random effects model. Because
the actual heterogeneity we found was low, we additionally
conducted the meta-analyses according to the fixed effects model.
In order to examine heterogeneity we calculated the I2 statistic,
which is an indicator of heterogeneity in percentages. A value of
0% indicates no observed heterogeneity, and larger values show
increasing heterogeneity (25% low, 50% moderate, 75% high).29
We calculated 95% confidence intervals around I 2,30 using
the non-central w2-based approach within the ‘heterogi’ module
for Stata/MP11.0 for Mac.31 To test for significant heterogeneity
we also calculated the Q statistic, but only report whether this
was significant or not. Subgroup analyses were conducted
according to the mixed effect model, in which studies within
subgroups are pooled with the random effects model, whereas
tests for significant differences between subgroups are conducted
with the fixed effects model. Because the actual heterogeneity
we found was low in most analyses, we also conducted the
subgroup analyses using the fixed effects model to examine both
within-group and between-group differences.
Publication bias was tested by inspecting the funnel plot and
by Duval & Tweedie’s trim and fill procedure,32 which yields an
estimate of the effect size after the publication bias has been taken
into account (as implemented in Comprehensive Meta-analysis
for Windows version 2.2.021). We also conducted Egger’s test of
the intercept to quantify the bias captured by the funnel plot
and tested whether it was significant.
We expected that the mortality rate in subthreshold depression
would be lower than in major depression, but that the prevalence
of subthreshold depression would be higher. This would make it
possible that the overall impact of subthreshold depression on
mortality rates is comparable to or higher than the impact of
major depression. In order to examine this we calculated the
population attributable fraction (PAF) of major depression and
subthreshold depression. The PAF indicates the potential reduction
in mortality if the adverse effect of depression were to be
completely blocked.33,34 We based the overall PAF of subthreshold
depression and major depression on the pooled prevalence rates
and the pooled mortality rates. Although the PAF assumes that
the excess mortality is fully caused by depression, which is not
the case (see Discussion), it does give an indication of the
relevance of subthreshold and major depression from a public
health perspective.
Results
Having examined 6694 abstracts (5919 after removal of duplicates),
we retrieved 975 full-text papers for further consideration. We
excluded 953 of the retrieved papers (Fig. 1). Twenty-two studies
23















No depression measure 189
Insufficient data to calculate RR 39
No data on overall mortality 152
No risk of depression on mortality 177
No non-depressed controls 33
Duplicate studies 68
No comparison of major v. minor
depression 232
Based on data for a trial 50
Other reason 13
Fig. 1 Flowchart of inclusion of studies: RR, relative risk.
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examined both major and subthreshold depression and were
included in this meta-analysis.35–56
Characteristics of included studies
Selected characteristics of the 22 included studies are presented in
online Table DS2. These studies included 18 705 participants
(1147 had a diagnosed depressive disorder, 3238 had subthreshold
depression and 14 320 had no depression), of whom 2881 died
during follow-up. Seven studies were conducted among
community samples, six among heart disease patients and nine
in other patient groups (two on stroke patients, two on cancer
patients, two on medical in-patients with diverse diagnoses, one
on dementia patients, one on nursing home residents and one
on patients with their first diabetic foot ulcer). Seven studies
included less than 40% women, six 40–60% women and seven
more than 60% women. Thirteen studies used a cut-off score on
a self-report questionnaire to define subthreshold depression,
whereas the other nine studies used diagnostic criteria for minor
depression (such as Research Diagnostic Criteria or the criteria
given in DSM-IV). Nine studies had a follow-up period of less
than 2 years, eight studies had a follow-up period of 2–5 years
and in four studies the follow-up was more than 5 years. Nine
studies were conducted in the USA, seven in Europe and six in
other countries. Nine studies scored positive on at least four of
the five quality criteria, whereas the remaining 13 studies scored
lower (online Table DS1).
Mortality in major v. subthreshold depression
We examined the relative risk of dying in patients with major
depression compared with those with subthreshold depression
(Table 1, Fig. 2). The risk was 1.13 (95% CI 0.98–1.30, random
effects model), indicating a somewhat increased risk of dying
for major depression compared with subthreshold depression.
This RR was not significant, although there was a trend
(P= 0.10 in the random effects model and P= 0.06 in the fixed
effects model) indicating an increased mortality risk in major
depression. Heterogeneity was low and not significant (P40.1).
The RR after adjustment for publication bias was exactly the same
as the unadjusted RR (one trimmed study), and Egger’s test of the
intercept was not significant (P40.1). We found no significant
difference between any of the subgroups with the random effects
model or with the fixed effects model (Table 1). Because the
differences between the models were small, we report only the
results according to the random effects model, which is the
optimal model.
Comparisons with participants without depression
We compared the mortality rates in major and subthreshold
depression respectively with the rate in participants without
depression. As indicated, we did this only to verify that the two
forms of depression were associated with a higher mortality rate
compared with participants without depression in our sample of
studies, as suggested in earlier meta-analyses. We found that
the relative risk of dying in major depression compared with
participants without depression was 1.58 (95% CI 1.31–1.89,
P50.001) in the random effects model, with moderate to
high heterogeneity (I 2 = 56%, P50.01). The RR of dying in
subthreshold depression compared with participants without
depression was smaller than in major depressive disorders
(RR = 1.33, 95% CI 1.11–1.61, random effects model) with high
24
Table 1 Meta-analyses of studies examining mortality in participants with major depression, subthreshold depression or no
depression: relative risksa
n RR 95% CI I 2 b 95% CI
Major v. subthreshold depression 22 1.13 0.98–1.30 13.32 0–48
Subgroup analysesc
Population
Community 7 1.04 0.85–1.27 0 0–71
Heart disease 6 1.05 0.66–1.67 24.19 0–68
Other patient group 9 1.24 0.95–1.64 41.23 0–73
Subthreshold depression
Self-reported 13 1.15 0.97–1.36 8.12 0–46
Diagnostic criteria 9 1.07 0.78–1.45 27.72 0–66
Country
USA 9 1.12 0.82–1.54 41.62 0–73
Europe 7 1.01 0.79–1.30 0 0–71
Other 6 1.18 0.98–1.43 0 0–75
Follow-upd
52 years 9 1.08 0.68–1.72 47.79 0–76
2–5 years 8 1.11 0.94–1.31 0 0–68
45 years 4 1.06 0.84–1.35 0 0–85
Quality score
4 or higher 9 1.19 0.95–1.48 36.25 0–71
Lower than 4 13 1.06 0.88–1.29 0 0–57
Proportion of womene
540% 7 1.16 0.70–1.91 23.93 0–66
40–60% 6 1.01 0.81–1.28 0 0–75
460% 7 1.19 0.96–1.48 24.96 0–67
Other comparisons
Major depression v. non-depressed 22 1.58 1.31–1.89*** 52.87** 52–80
Subthreshold depression v. non-depressed 22 1.33 1.11–1.61** 69.13*** 23–71
a. All reported results are based on the random effects model.
b. The P values in this column indicate whether the Q statistic is significant.
c. None of the differences between the effect sizes in the subgroups was significant.
d. The study of von Ammon Cavanaugh et al 55 did not report the exact follow-up period and was excluded from these analyses.
e. Two studies in which the percentage of female participants was not reported were excluded (Jorm et al, 1991;42 von Ammon Cavanaugh et al, 200155).
**P50.01, ***P50.001.
Mortality rates in depression
heterogeneity (I 2 = 69%, P50.001). The results of the fixed effects
models were comparable (not presented in Table 1).
Population attributable fraction
The pooled prevalence rate of subthreshold depression was 0.17
(95% CI 0.10–0.28, random effects model) which was somewhat
higher than the pooled prevalence rate of major depressive
disorder (0.10, 95% CI 0.06–0.16); the case–control study by
Sharma et al was excluded from the latter prevalence estimate.52
To examine the overall impact of major depression and
subthreshold depression on mortality in the population, we
calculated the population attributable fraction of major
depression and subthreshold depression. We found that the PAF
of major and subthreshold depression together was 0.137,
indicating that the overall mortality would be reduced by 14% if
the adverse effects of depression could be blocked completely.
The PAF of subthreshold depression was 0.065 and that of major
depression was 0.072, indicating that the impact on mortality of
the two types of depression are comparable.
Discussion
Direct comparisons between the mortality rates in major depression
and subthreshold depression showed that there was a trend
(P50.1) indicating that the mortality rate in people with major
depression may be somewhat higher than in people with
subthreshold depression (RR = 1.13). We also found that both
major depression (RR = 1.58) and subthreshold depression
(RR = 1.33) were associated with a significantly increased risk of
mortality compared with non-depressed samples (P50.001). This
is in agreement with the findings of most earlier meta-analyses.
Together, these findings suggest that both major and subthreshold
depression are associated with increased mortality rates, but that
there is not much difference between the rates in the two types
of depression. This is further strengthened by the findings on
the PAF. We found that the PAFs of both major and subthreshold
depression are about 0.07. This indicates that mortality would
decline by 7% if we could block the adverse effects of major
depression, and by another 7% if we could block the adverse
effects of subthreshold depression. Although the risk of dying is
somewhat higher in major depression the prevalence of major
depression is lower, resulting in comparable PAFs. This is in
agreement with other research showing that the impact of sub-
threshold depression on quality of life, service use and economic
costs is lower than in major depression on an individual level,16,20
but that it is comparable with major depression on the population
level because of the higher prevalence.
The relative risks we found for major and subthreshold
depression compared with non-depressed controls were somewhat
lower than in most other meta-analyses.4,7,25 Although higher RR
was not confirmed in all meta-analyses,27 this could indicate that
our sample of studies was not representative of all studies
examining the association between depression and mortality.
However, because there is no clear consensus between the different
meta-analyses it is not possible to verify this, and further research
is needed to confirm it.
Limitations
This study has several limitations. First, although the number of
studies was relatively large, the number of participants with major
or subthreshold depression was not. Because we were interested in
the differential mortality rates in these two conditions, we may not
have had sufficient statistical power to detect smaller differences
between the two groups. On the other hand, the 95% confidence
interval of the RR ranged from 0.98 to 1.30, which indicates that it
is unlikely that the ultimate risk is larger than 1.30. This would
still only be an association of limited strength. A second limitation
is that the quality of the studies was not optimal in all cases. This
may have influenced our results, although we did not find
significant differences between higher- and lower-quality studies.
Third, we were only capable of examining unadjusted associations
between major v. subthreshold depression and mortality. There is
much evidence showing that a large part of the association
between depression and excess mortality can be explained by
lifestyle, behavioural and illness- related factors, although it is
unclear whether this is also relevant for the comparison between
major and subthreshold depression. Nonetheless, it is possible that
had we adjusted for these factors the association between major v.
subthreshold depression and mortality might have changed,
although the direction of such a change cannot be predicted. More
research is certainly warranted to explore this issue further.
Fourth, in the included studies depression was measured only
once (at baseline). It is highly possible that participants with
subthreshold depression met criteria for major depression at some
time in their past or during the follow-up period, that participants
without depression had had a depressive disorder at some point in
their life, and that participants with major depression did not
meet diagnostic criteria 1 month earlier. This might well have
distorted our outcomes. Because of these limitations the results
of our studies have to be considered with caution.
Implications
It is not yet clear what the exact causes are of the increased
mortality rates in people with depressive disorders. There is
evidence that part of the excess mortality can be explained by
an increased risk of suicide in people with depression,57 by
hazardous health behaviours such as physical inactivity,58
increased smoking rates,59 more alcohol consumption and
unhealthy eating patterns,35,60,61 and by biological dysregulation,
including hyperactivity of the hypothalamic–pituitary–adrenal
axis, neuroimmune dysregulation and sympathoadrenergic
dysregulation.62–64 However, it remains unclear for most of these
25





































































































































Fig. 2 Studies directly comparing mortality rates in major
and subthreshold depression: relative risks.
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explanatory mechanisms what the causal direction is. It is possible
that depressive disorders lead to hazardous health behaviours and
biological dysregulation, but it is also possible that these factors
have a role in the development of depressive disorders, or that
both are explained by a third, underlying factor.
This study has made it clear that the association between
depression and excess mortality is not limited to major
depression. Apparently, the mechanisms through which
depression is associated with mortality are also working in less
severe forms of depression. It makes sense that unhealthy lifestyles
as well as biological pathways are responsible for the excess
mortality in major as well as subthreshold depression. These
findings suggest that depression should not be seen as a distinct
category with unique characteristics, but rather as a continuum
ranging from no depression on the one hand to severe depression
on the other, with subthreshold depression in between.65,66
Another implication of our findings is that the effects of sub-
threshold depression might be less severe than those of major
depression in individual cases, but because of its high prevalence
the impact on public health is comparable with that of major
depression. This could be seen as an indication that subthreshold
depression is a clinically relevant condition that does require
treatment. Although there is no evidence that antidepressants
and benzodiazepines are effective for this condition,67 brief
psychological treatments have been shown to be effective.68
Future research
We found little evidence that excess mortality is much higher in
major depression than in subthreshold disorder, and in terms of
population impact the two are comparable. More research on
the exact mechanisms through which depression is associated with
excess mortality might help in further understanding and possibly
reducing this excess mortality.
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